Dare Bioscience, Inc. ( DARE) - Stock Earnings
DARE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
DARE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -1.4 million USD | 1.0 million USD |
| 2026Q1 | -3.0 million USD | 152455 USD |
| 2026Q2 | -3.0 million USD | 187546 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
DARE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.2 million USD | 2.8 million USD |
| 2024 | -4.1 million USD | 9784 USD |
| 2025 | -13.4 million USD | 1.0 million USD |
| 2026 Est. | — | — |
DARE
Price: $0.73
Earnings Per Share: -0.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 12.6 million